Neural signatures of saliency-mapping in anhedonia: A narrative review.


Journal

Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385

Informations de publication

Date de publication:
10 2021
Historique:
received: 27 01 2021
revised: 09 07 2021
accepted: 14 07 2021
pubmed: 2 8 2021
medline: 28 10 2021
entrez: 1 8 2021
Statut: ppublish

Résumé

Anhedonia is the loss of pleasure or motivation to engage in previously enjoyable activities, and is a transdiagnostic symptom associated with significant clinical impairment. Anhedonia is implicated in several different psychiatric disorders, presenting a promising opportunity for transdiagnostic treatment. Thus, developing targeted treatments for anhedonia is of critical importance for population mental health. An important first step in doing so is establishing a thorough understanding of the neural correlates of anhedonia. The Triple Network Model of Psychopathology provides a frame for how brain activity may go awry in anhedonia, specifically in the context of Salience Network (SN) function (i.e., saliency-mapping). We present a narrative review examining saliency-mapping as it relates to anhedonia severity in depressed and transdiagnostic adult samples. Results revealed increased anhedonia to be associated with hyperactivity of the SN at rest and in the context of negative stimuli, as well as a global lack of SN engagement in the context of positive stimuli. Potential treatments for anhedonia are placed within this model, and future directions for research are discussed.

Identifiants

pubmed: 34333324
pii: S0165-1781(21)00419-4
doi: 10.1016/j.psychres.2021.114123
pmc: PMC8759627
mid: NIHMS1767579
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

114123

Subventions

Organisme : NIMH NIH HHS
ID : F31 MH120900
Pays : United States
Organisme : NIA NIH HHS
ID : K01 AG053539
Pays : United States
Organisme : NIMH NIH HHS
ID : R33 MH110027
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG058160
Pays : United States

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Références

Brain Res Brain Res Rev. 1999 Dec;31(1):6-41
pubmed: 10611493
J Neurosci. 2008 Nov 12;28(46):11825-9
pubmed: 19005047
Nat Med. 2020 May;26(5):760-768
pubmed: 32231295
Behav Modif. 2011 Mar;35(2):111-61
pubmed: 21324944
J Psychiatr Res. 2013 Oct;47(10):1319-28
pubmed: 23791396
Neuroimage. 2009 May 15;46(1):327-37
pubmed: 19457367
Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):11073-8
pubmed: 17576922
Biol Psychiatry. 2003 Sep 1;54(5):573-83
pubmed: 12946886
Neuropsychopharmacology. 2008 Jan;33(2):368-77
pubmed: 17429407
Am J Psychiatry. 2010 Jul;167(7):748-51
pubmed: 20595427
J Affect Disord. 2021 Jul 1;290:308-315
pubmed: 34020205
Trends Cogn Sci. 2008 Mar;12(3):81-3
pubmed: 18243042
Psychol Med. 1996 May;26(3):477-86
pubmed: 8733206
Brain. 2017 Apr 1;140(4):1147-1157
pubmed: 28334960
Biol Psychiatry. 2005 Dec 1;58(11):843-53
pubmed: 16043128
J Affect Disord. 2017 Aug 15;218:284-290
pubmed: 28478357
J Psychiatry Neurosci. 2013 Jul;38(4):249-58
pubmed: 23171695
Nature. 2006 Aug 31;442(7106):1042-5
pubmed: 16929307
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:109-117
pubmed: 30611836
Nat Neurosci. 2006 Jul;9(7):971-8
pubmed: 16767087
Arch Gen Psychiatry. 1983 Jan;40(1):79-84
pubmed: 6849623
Trends Cogn Sci. 2011 Oct;15(10):483-506
pubmed: 21908230
J Affect Disord. 2016 Oct;203:143-151
pubmed: 27288959
Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):6106-11
pubmed: 20220100
J Abnorm Psychol. 1976 Aug;85(4):374-82
pubmed: 956504
Biol Psychol. 2017 Feb;123:62-73
pubmed: 27876651
Am J Psychiatry. 2017 Jul 1;174(7):657-666
pubmed: 28135847
Neuropsychopharmacology. 2018 Nov;43(12):2445-2451
pubmed: 29795403
World J Biol Psychiatry. 2018 Oct;19(7):497-508
pubmed: 28789578
Acta Psychiatr Scand. 2001 Feb;103(2):122-30
pubmed: 11167315
Depress Anxiety. 2017 Nov;34(11):1049-1056
pubmed: 28632961
CNS Neurosci Ther. 2018 Jul;24(7):615-623
pubmed: 29687627
J Affect Disord. 2019 Jan 15;243:188-192
pubmed: 30245249
Trends Cogn Sci. 2007 Jun;11(6):229-35
pubmed: 17475536
J Affect Disord. 2017 Oct 15;221:289-296
pubmed: 28668590
Brain Res Brain Res Rev. 1998 Dec;28(3):309-69
pubmed: 9858756
Br J Soc Clin Psychol. 1967 Dec;6(4):278-96
pubmed: 6080235
Biol Psychiatry. 2006 Aug 15;60(4):383-7
pubmed: 16780813
Annu Rev Clin Psychol. 2012;8:49-76
pubmed: 22224834
Psychol Assess. 2010 Sep;22(3):702-10
pubmed: 20822283
Transl Psychiatry. 2019 Sep 3;9(1):217
pubmed: 31481688
Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):4690-5
pubmed: 22393019
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Mol Psychiatry. 2016 Oct;21(10):1358-65
pubmed: 26552591
Biol Psychiatry. 2014 Aug 1;76(3):176-85
pubmed: 24388670
Biol Psychiatry. 2009 Nov 1;66(9):886-97
pubmed: 19726030
Psychiatry Res Neuroimaging. 2018 May 30;275:21-27
pubmed: 29555382
Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19944-9
pubmed: 24248372
Neuropsychopharmacology. 2017 Mar;42(4):831-843
pubmed: 27585739
J Affect Disord. 2016 Oct;203:204-212
pubmed: 27295377
Soc Cogn Affect Neurosci. 2015 Aug;10(8):1102-12
pubmed: 25567763
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9673-8
pubmed: 15976020
J Affect Disord. 2018 Aug 15;236:101-104
pubmed: 29723763
Biol Psychiatry. 2013 Jun 15;73(12):1204-12
pubmed: 23562618
Am J Psychiatry. 2009 Jun;166(6):702-10
pubmed: 19411368
Nat Med. 2021 Feb;27(2):229-231
pubmed: 33462446
Biol Psychiatry. 2010 Jan 15;67(2):110-6
pubmed: 19914605
Trends Neurosci. 2012 Jan;35(1):68-77
pubmed: 22177980
Brain Stimul. 2017 Jan - Feb;10(1):165-167
pubmed: 28017321
Am J Psychiatry. 2015 Sep 1;172(9):881-91
pubmed: 26183698
Front Hum Neurosci. 2014 Apr 28;8:248
pubmed: 24808845
Mol Psychiatry. 2017 Feb;22(2):202-208
pubmed: 27240528
J Consult Clin Psychol. 2014 Feb;82(1):122-9
pubmed: 24219183
Neuroscience. 2006 Apr 28;139(1):51-8
pubmed: 16352402
Philos Trans R Soc Lond B Biol Sci. 2005 Apr 29;360(1456):781-95
pubmed: 15937012
J Consult Clin Psychol. 1973 Oct;41(2):261-8
pubmed: 4147832
Biol Psychiatry. 2013 Apr 1;73(7):639-45
pubmed: 23228328
J Am Acad Child Adolesc Psychiatry. 2012 Apr;51(4):404-11
pubmed: 22449646
Annu Rev Neurosci. 2001;24:167-202
pubmed: 11283309
Soc Cogn Affect Neurosci. 2017 Sep 1;12(9):1520-1533
pubmed: 28575424
Neuron. 2011 Nov 17;72(4):665-78
pubmed: 22099467
J Neurosci. 2017 Apr 19;37(16):4370-4380
pubmed: 28283562
Mol Psychiatry. 2007 Aug;12(8):703, 767-75
pubmed: 17505465
J Psychiatr Res. 2018 Aug;103:61-68
pubmed: 29783076
Brain Struct Funct. 2010 Jun;214(5-6):655-67
pubmed: 20512370
Neuropsychologia. 2018 Mar;111:172-179
pubmed: 29408479
Transl Psychiatry. 2016 May 17;6:e810
pubmed: 27187232
Depress Anxiety. 2018 May;35(5):382-392
pubmed: 29232491
J Abnorm Psychol. 1995 Feb;104(1):15-25
pubmed: 7897037
J Psychopharmacol. 2015 May;29(5):596-607
pubmed: 25691504
J Psychiatr Res. 2015 Sep;68:384-91
pubmed: 26070246
Br J Psychiatry. 1995 Jul;167(1):99-103
pubmed: 7551619
Biol Psychiatry. 2011 Nov 15;70(10):962-8
pubmed: 21867991
Transl Psychiatry. 2021 Feb 24;11(1):138
pubmed: 33627624
Biol Psychiatry. 2009 Jan 1;65(1):63-74
pubmed: 18996505
Neuropsychopharmacology. 2012 Aug;37(9):1975-85
pubmed: 22473055
J Neurosci. 2006 Jan 4;26(1):186-92
pubmed: 16399686
Cereb Cortex. 2009 Oct;19(10):2209-29
pubmed: 19221144
J Subst Abuse Treat. 2018 Sep;92:46-50
pubmed: 30032944
Neuron. 2003 Apr 24;38(2):339-46
pubmed: 12718866
Neuroimage. 2019 Jan 15;185:425-433
pubmed: 30385222
Transl Psychiatry. 2019 Nov 11;9(1):293
pubmed: 31712555
J Affect Disord. 2017 Jan 01;207:377-383
pubmed: 27750155

Auteurs

Angela Pisoni (A)

Department of Psychology and Neuroscience, Duke University, Durham, NC, USA. Electronic address: angela.pisoni@duke.edu.

Simon W Davis (SW)

Department of Neurology, Duke University Medical Center, Durham, NC, USA; Center for Cognitive Neuroscience, Duke University, Durham, NC, USA. Electronic address: simon.davis@duke.edu.

Moria Smoski (M)

Department of Psychology and Neuroscience, Duke University, Durham, NC, USA; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA. Electronic address: moria.smoski@duke.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH